September 3, 2025 12:57 pm EDT Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
August 11, 2025 7:00 am EDT Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025